A mammary adenocarcinoma murine model suitable for the study of cancer immunoediting

La inmunoedición del cáncer es un proceso dinámico compuesto de tres fases: eliminación (EL), equilibrio (EQ) y escape (ES) que abarca las posibles funciones protectoras del huésped y de esculpir el tumor del sistema inmunitario durante el desarrollo del tumor. Los modelos animales son herramientas...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pagura, Lucas, Cáceres, Juan Manuel, Cardinale, Albertina, Scharovsky, O. Graciela, Di Masso, Ricardo José, Zacarías-Fluck, Mariano, Rico, María José, Rozados, Viviana R.
Formato:	article artículo publishedVersion
Lenguaje:	Inglés
Publicado:	BioMed Central 2018
Materias:	Cancer immunoediting Murine models Mammary adenocarcinoma Mathematical model
Acceso en línea:	http://hdl.handle.net/2133/11489 http://hdl.handle.net/2133/11489
Aporte de:	Repositorio Hipermedial de la Universidad Nacional de Rosario (UNR) de Universidad Nacional de Rosario

Ejemplares similares

Empleo de un modelo murino original de Argentina en la caracterización de fenotipos complejos
por: Hinrichsen, Lucila Isabel, et al.
Publicado: (2017)

¿Cómo generar un modelo tridimensional <i>in vitro</i> a partir de un adenocarcinoma mamario murino?
por: Palma, María Belén, et al.
Publicado: (2018)

Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential
por: Urtreger, A.J., et al.

Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential
Publicado: (2006)

Growth inhibition in vitro of murine mammary adenocarcinoma cells by heparin and chemically modified heparins
por: Bertolesi, G.E., et al.

Growth inhibition in vitro of murine mammary adenocarcinoma cells by heparin and chemically modified heparins
Publicado: (1994)

Reversal of estrogen-resistance in murine mammary adenocarcinomas
por: Montecchia, M.F., et al.

Reversal of estrogen-resistance in murine mammary adenocarcinomas
Publicado: (1999)

Antitumor activity of new chemical compounds in triple negative mammary adenocarcinoma models
por: Giolito, Maria Virginia, et al.
Publicado: (2020)

Influence of mast cells on two murine mammary adenocarcinomas
por: De Cidre, L.L., et al.

Influence of mast cells on two murine mammary adenocarcinomas
por: Eijan, Ana María, et al.
Publicado: (1996)

δ-aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters
por: Bermúdez Moretti, M., et al.

δ-aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters
por: Bermudez Moretti, Mariana, et al.
Publicado: (2002)

Correlation between urokinase‐type plasminogen activator production and the metastasizing ability of two murine mammary adenocarcinomas
Publicado: (1988)

Correlation between urokinase-type plasminogen activator production and the metastasizing ability of two murine mammary adenocarcinomas
por: Pereyra-Alfonso, S., et al.

Correlation between urokinase-type plasminogen activator production and the metastasizing ability of two murine mammary adenocarcinomas
Publicado: (1988)

Supplementary Materials - Antitumor activity of new chemical compounds in triple negative mammary adenocarcinoma models
por: Giolito, Maria Virginia, et al.
Publicado: (2020)

In vitro photosensitisation of a murine mammary adenocarcinoma cell line with Verteporfin.
por: Casas, A., et al.

In vitro photosensitisation of a murine mammary adenocarcinoma cell line with Verteporfin.
por: Casas, Adriana Gabriela, et al.
Publicado: (2002)

Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition
por: Bertolesix, G.E., et al.

Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition
por: Eijan, Ana María
Publicado: (1995)

Comparative Effectiveness of Two Metronomic Chemotherapy Schedules. Our Experience in the Preclinical Field
por: Rico, María José, et al.
Publicado: (2018)

Establishment and characterization of a new metastatic cell line (M3MC) derived from a murine mammary tumor
por: Lucero Gritti, M.F., et al.

Establishment and characterization of a new metastatic cell line (M3MC) derived from a murine mammary tumor
Publicado: (1994)

Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability
por: Guerra, F.K., et al.

Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability
Publicado: (1996)

Protection efficacy of Argentinian isolates of Mycobacterium avium subsp. paratuberculosis with different genotypes and virulence in a murine model
por: Colombatti Olivieri, María Alejandra, et al.
Publicado: (2018)

Manifestaciones tomográficas del adenocarcinoma pulmonar
por: Turina, A, et al.
Publicado: (2024)

Development of a murine colonization model of Lactobacillus plantarum LP5 of porcine origin.
por: Ruiz, M J
Publicado: (2021)

Lung adenocarcinoma on scar of previous segmentectomy for benign nodule. Case presentation
por: Uad, Pedro, et al.
Publicado: (2020)

Therapeutic efficacy of metronomic chemotherapy with cyclophosphamide and doxorubicin on murine mammary adenocarcinomas
por: Mainetti, Leandro Ernesto, et al.
Publicado: (2018)

Effects of ω-3 PUFA-enriched diet on growth parameters in a syngenic murine model of breast adenocarcinoma: a possible role for estrogen receptor alpha
por: Vara Messler, Marianela, et al.
Publicado: (2022)

Niveles plasmáticos de antioxidantes en el adenocarcinoma de próstata
por: Uvilla, Ana Laura, et al.
Publicado: (2020)

Niveles plasmáticos de antioxidantes en el adenocarcinoma de próstata
por: Uvilla, Ana Laura, et al.
Publicado: (2020)

Reversal of estrogen-resistance in murine mammary adenocarcinomas
por: Montecchia, M.F
Publicado: (1999)

Transforming growth factor-β activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice
por: Elizalde, P.V., et al.

Transforming growth factor-β activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice
por: Elizalde, Patricia Virginia, et al.
Publicado: (1990)

Correlation of TGF-(si expression with medroxiprogesterone acetate responsiveness in mouse mammary adenocarcinomas
por: Elizalde, P.V., et al.

Correlation of TGF-(si expression with medroxiprogesterone acetate responsiveness in mouse mammary adenocarcinomas
Publicado: (1995)

Decay-accelerating factor 1 deficiency exacerbates leptospiral-induced murine chronic nephritis and renal fibrosis
por: Ferrer, María Florencia, et al.
Publicado: (2014)